Clinical Trial Update: Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Inetetamab with Paclitaxel, with or without Pertuzumab, for previously treated HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inetetamab (inetetamab)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Stage IV | Phase 4 | Status: NOT_YET_RECRUITING